Striatal cell-type-specific molecular signatures reveal therapeutic targets in a model of dystonia
Kaitlyn M. Roman, Ashok Reddy Dinasarapu, Suraj Cherian…·Ellen J. Hess
The paper identifies cell-type-specific molecular changes in dystonia by analyzing translatomes of dSPNs and iSPNs in DRD mice, revealing glutamatergic signaling disruptions and identifying LRRK2 inhibition as a therapeutic target.